It is known that H. pylori can directly activate oncogenic pathways, such as the MEK-ERK pathway and WNT pathway, and inactivate tumor-suppressive pathways, such as the p53 pathway, by injecting CagA into epithelial cells3. This evidence concerns the gene S100A8 and neoplasm.